Patterns of failure after use of 18F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases
暂无分享,去创建一个
[1] S. Rosenberg,et al. Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] S. Beriwal,et al. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. , 2014, International journal of radiation oncology, biology, physics.
[3] Wei-Chun Chang,et al. Low-Dose, Prophylactic, Extended-Field, Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin for Patients With Stage IB2-IIIB Cervical Cancer, Positive Pelvic Lymph Nodes, and Negative Para-aortic Lymph Nodes , 2014, International Journal of Gynecologic Cancer.
[4] Nikhil Wagle,et al. Oncogenic mutations in cervical cancer , 2013, Cancer.
[5] S. Beriwal,et al. Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysis. , 2013, Gynecologic oncology.
[6] D. D'Souza,et al. Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. , 2013, International journal of radiation oncology, biology, physics.
[7] John O. Prior,et al. The role of PET/CT in cervical cancer , 2013, Front. Oncol..
[8] Amy P Abernethy,et al. Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Akram Al-Ibraheem,et al. Evidence for the use PET for radiation therapy planning in patients with cervical cancer: a systematic review. , 2011, Hematology/oncology and stem cell therapy.
[10] C. Loiselle,et al. The emerging use of IMRT for treatment of cervical cancer. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.
[11] Sasa Mutic,et al. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. , 2010, International journal of radiation oncology, biology, physics.
[12] P. Grigsby,et al. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] Christian Kirisits,et al. Adaptive management of cervical cancer radiotherapy. , 2010, Seminars in radiation oncology.
[14] J. Dubuisson,et al. Early-stage cervical cancer: is surgery better than radiotherapy? , 2010, Expert review of anticancer therapy.
[15] P. Grigsby,et al. Prospective clinical trial of positron emission tomography/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes. , 2008, International journal of radiation oncology, biology, physics.
[16] Christian Kirisits,et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] Jun Duan,et al. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. , 2004, International journal of radiation oncology, biology, physics.
[18] J. Roeske,et al. Intensity-modulated radiation therapy in gynecologic malignancies , 2004, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[19] P. Maisonneuve,et al. Carcinoma of the cervix uteri , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[20] P. Grigsby,et al. Occult supraclavicular lymph node metastasis identified by FDG-PET in patients with carcinoma of the uterine cervix. , 2003, Gynecologic oncology.
[21] F Dehdashti,et al. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] P J Eifel,et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.
[23] G. Thomas. Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy. , 1999, The New England journal of medicine.
[24] A R Feinstein,et al. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.
[25] J. Dimopoulos,et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] P. Maisonneuve,et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[27] K. Blank,et al. Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer , 1999 .